Hjem

Centre for Cancer Biomarkers

Hovedinnhold

Centre for Cancer Biomarkers

Collage of photos from CCBIO situations; research, teaching, symposia.

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. See the 1 minute video CCBIO in a Nutshell. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO's principal investigators:

Cancer research
Microscopy image of AML cells.

Blood sample 24 hours after start of chemotherapy predicts survival

Acute myeloid leukemia is an aggressive blood cancer with poor survival. Younger and otherwise healthy patients undergo severe chemotherapy, often accompanied by stem cell transplant, even though it is difficult to predict who will benefit from the treatment. Now, a simple blood test can measure...

Support
Oddbjørn Straume sitting in his office.

Support to immunotherapy improving project

November 26, the regional health authorities Helse Vest announced their funding for 2023, allocating 182 million NOK to 57 new projects, and renewed support to 160 fellows and projects. Among the new projects, CCBIO PI Oddbjørn Straume receives open project support for his project "Targeting AXL to...

Support
Arne Östman standing in front of a CCBIO poster.

Potential biomarkers and drugs for common breast cancer

Professor Arne Östman in CCBIO's International Faculty receives financial support from the Western Norway regional health authorities Helse Vest in their 2023 allocation. His project "Novel biomarkers and combination treatments for ER+ breast cancer" receives NOK 1.500.000 in the first year.

support
Portrait of Carina Strell.

Pioneer project increasing the efficacy of immunotherapy

The Norwegian Cancer Society has a new funding program, the Norwegian Cancer Society Pioneer Projects, which supports early-stage exploration of novel and innovative ideas with potential for breaking new grounds in cancer research. CCBIO Associate Investigator Carina Strell just got the news that...

News
Collage of photos from the Scanpath meeting, with people interacting.

Record attendance at this year’s SCANPATH meeting

CCBIO hosted the 6th SCANPATH meeting – Scandinavian Seminar on Translational Pathology – on November 14 and 15 at Solstrand Hotel, close to Bergen (Norway). Top Scandinavian tumor pathologist and pre-clinical scientists came to present and discuss tissue-based studies of tumor mechanisms and...

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.